Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Real-world Reduction in Oral Corticosteroid Utilization Following Efgartigimod Initiation in Patients Living with Generalized Myasthenia Gravis

Author:Goyal, Neelam   Qi, Cynthia   Stone, John   Gelinas, Deborah   Jefferson, Matthew   Suthagar, Tharun Balaji   Menon, Rohit R   Goyal, Amit   Phillips, Glenn   

Session Name:S38: Autoimmune Neurology: Peripheral Autoimmunity, Paraneoplastic Disease, Checkpoint Inhibitors, and Neurosarcoidosis  

Topic:Autoimmune Neurology  

Program Number:S38.002  

Author Institution:Stanford University, Palo Alto, CA  argenx, Boston, MA  Harvard Medical School, Boston, MA  ZS Associates, Bengaluru, India  ZS Associates, Princeton, NJ  

Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-mediated Autoimmune Diseases

Author:Vu, Tuan   Gwathmey, Kelly   Broome, Catherine   Goebeler, Matthias   Murai, Hiroyuki   Bata-Csörgo, Zsuzsanna   Newland, Adrian   Ulrichts, Peter   Kerstens, Rene   Guptill, Jeffrey T.   Agha, Sofiane   Jiang, Ming   Howard, James   

Session Name:P4: Autoimmune Neurology: Peripheral Autoimmunity  

Topic:Autoimmune Neurology  

Program Number:P4.016  

Author Institution:University of South Florida, Tampa, FL  Virginia Commonwealth University, Henrico, VA  Georgetown University, Washington, DC  University Hospital Würzburg, Würzburg, Germany  International University of Health and Welfare, Narita, Japan  University of Szeged, Szeged, Hungary  Barts and the London School of Medicine and Dentistry, London, United Kingdom  argenx, Boston, MA  argenx, Ghent , Belgium  argenx, Ghent, Belgium  The University of North Carolina, Dept of Neurology, CB 7025, Chapel Hill, NC